{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:51:56Z","timestamp":1783338716782,"version":"3.54.6"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10689-021-00268-8","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T04:53:37Z","timestamp":1624337617000},"page":"337-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A patient with very early onset FH-deficient renal cell carcinoma diagnosed at age seven"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6735-0214","authenticated-orcid":false,"given":"Rieko","family":"Taniguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Wakamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoharu","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyoe","family":"Shirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinari","family":"Hinoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Tainaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyonori","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"268_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","volume":"13","author":"FH Menko","year":"2014","unstructured":"Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittom\u00e4ki K, Tomlinson I, Richard S, Linehan WM (2014) Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer 13:637\u2013644","journal-title":"Fam Cancer"},{"key":"268_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/cge.13014","volume":"92","author":"M Muller","year":"2017","unstructured":"Muller M, Ferlicot S, Guillaud-Bataille M, Le Teuff G, Genestie C, Deveaux S, Slama A, Poulalhon N, Escudier B, Albiges L, Soufir N, Avril MF, Gardie B, Saldana C, Allory Y, Gimenez-Roqueplo AP, Bressac-de Paillerets B, Richard S, Benusiglio PR (2017) Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers. Clin Genet 92:606\u2013615","journal-title":"Clin Genet"},{"key":"268_CR3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.euo.2019.11.002","volume":"3","author":"C Forde","year":"2019","unstructured":"Forde C, Lim DHK, Alwan Y, Burghel G, Butland L, Cleaver R, Dixit A, Evans DG, Hanson H, Lalloo F, Oliveira P, Vialard L, Wallis Y, Maher ER, Woodward ER (2019) Hereditary leiomyomatosis and renal cell cancer: clinical, molecular, and screening features in a cohort of 185 affected individuals. Eur Urol Oncol 3:764\u2013772","journal-title":"Eur Urol Oncol"},{"key":"268_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-020-01653-9","volume":"16","author":"Z Chayed","year":"2021","unstructured":"Chayed Z, Kristensen LK, Ousager LB, R\u00f8nlund K, Bygum A (2021) Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review. Orphanet J Rare Dis 16:34","journal-title":"Orphanet J Rare Dis"},{"key":"268_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-Part A: renal, penile, and testicular tumours. Eur Urol 70:93\u2013105","journal-title":"Eur Urol"},{"key":"268_CR6","doi-asserted-by":"publisher","first-page":"e810","DOI":"10.1016\/j.juro.2012.02.2170","volume":"187","author":"J Nix","year":"2012","unstructured":"Nix J, Shuch B, Chen V, Middleton L, Peterson J, Gautam R, Merino M, Metwalli A, Bratslavsky G, Pinto P, Srinivasan R, Linehan M (2012) Clinical features and management of hereditary leiomyomatosis and renal cell cancer (HLRCC). J Urol 187:e810","journal-title":"J Urol"},{"key":"268_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26823","author":"R Taniguchi","year":"2018","unstructured":"Taniguchi R, Muramatsu H, Okuno Y, Suzuki K, Obu S, Nakatochi M, Shimamura T, Takahashi Y, Horikoshi Y, Watanabe K, Kojima S (2018) Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.26823","journal-title":"Pediatr Blood Cancer"},{"key":"268_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12894-019-0484-2","volume":"19","author":"I Park","year":"2019","unstructured":"Park I, Shim YS, Go H, Hong BS, Lee JL (2019) Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures. BMC Urol 19:51","journal-title":"BMC Urol"},{"key":"268_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2007.02.005","volume":"11","author":"PJ Pollard","year":"2007","unstructured":"Pollard PJ, Spencer-Dene B, Shukla D, Howarth K, Nye E, El-Bahrawy M, Deheragoda M, Joannou M, McDonald S, Martin A, Igarashi P, Varsani-Brown S, Rosewell I, Poulsom R, Maxwell P, Stamp GW, Tomlinson IP (2007) Targeted inactivation of FH1 causes proliferative renal cyst development and activation of the hypoxia pathway. Cancer Cell 11:311\u2013319","journal-title":"Cancer Cell"},{"key":"268_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0022-5347(05)65373-6","volume":"167","author":"N Terada","year":"2002","unstructured":"Terada N, Ichioka K, Matsuta Y, Okubo K, Yoshimura K, Arai Y (2002) The natural history of simple renal cysts. J Urol 167:21\u201323","journal-title":"J Urol"},{"key":"268_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/jmg.2005.036400","volume":"43","author":"HJ Lehtonen","year":"2006","unstructured":"Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK, Salovaara R, Herva R, Koivisto PA, Vierimaa O, Aittom\u00e4ki K, Pukkala E, Launonen V, Aaltonen LA (2006) Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 43:523\u2013526","journal-title":"J Med Genet"},{"key":"268_CR12","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.3390\/cancers12113277","volume":"12","author":"AB S\u00e1nchez-Heras","year":"2020","unstructured":"S\u00e1nchez-Heras AB, Castillejo A, Garc\u00eda-D\u00edaz JD, Robledo M, Teul\u00e9 A, S\u00e1nchez R, Z\u00fa\u00f1iga \u00c1, Lastra E, Dur\u00e1n M, Llort G, Yag\u00fce C, Ramon Y, Cajal T, L\u00f3pez S, Martin C, L\u00f3pez-Fern\u00e1ndez A, Balma\u00f1a J, Robles L, Mesa-Latorre JM, Chirivella I, Fonfria M, Perea Iba\u00f1ez R, Castillejo MI, Escandell I, Gomez L, Berbel P, Soto JL (2020) Hereditary leiomyomatosis and renal cell cancer syndrome in Spain: clinical and genetic characterization. Cancers (Basel) 12:3277","journal-title":"Cancers (Basel)"},{"key":"268_CR13","first-page":"303872","volume":"2015","author":"BT Ristau","year":"2015","unstructured":"Ristau BT, Kamat SN, Tarin TV (2015) Abnormal cystic tumor in a patient with hereditary leiomyomatosis and renal cell cancer syndrome: evidence of a precursor lesion? Case Rep Urol 2015:303872","journal-title":"Case Rep Urol"},{"key":"268_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10689-019-00155-3","volume":"19","author":"JA Hol","year":"2020","unstructured":"Hol JA, Jongmans MCJ, Littooij AS, de Krijger RR, Kuiper RP, van Harssel JJT, Mensenkamp A, Simons M, Tytgat GAM, van den Heuvel-Eibrink MM, van Grotel M (2020) Renal cell carcinoma in young FH mutation carriers: case series and review of the literature. Fam Cancer 19:55\u201363","journal-title":"Fam Cancer"},{"key":"268_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2133.2005.06678.x","volume":"153","author":"NA Alam","year":"2005","unstructured":"Alam NA, Olpin S, Leigh IM (2005) Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol 153:11\u201317","journal-title":"Br J Dermatol"},{"key":"268_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/jmg.2010.085068","volume":"48","author":"B Gardie","year":"2011","unstructured":"Gardie B, Remenieras A, Kattygnarath D et al (2011) Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet 48:226\u2013234","journal-title":"J Med Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00268-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-021-00268-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00268-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T07:18:46Z","timestamp":1655363926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-021-00268-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["268"],"URL":"https:\/\/doi.org\/10.1007\/s10689-021-00268-8","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"10 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was approved by the Ethics Committee of Nagoya University Graduate School of Medicine (No. 2016-0025).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient\u2019s parents. The patient\u2019s parents consented to publication of deidentified information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}